Status | Study |
RECRUITING |
Study Name: A Study of Bomedemstat (MK-3543) in Participants With Polycythemia Vera (MK-3543-004) Condition: Polycythemia Vera Date: 2022-09-20 Interventions: Oral tablet |
Active, not recruiting |
Study Name: A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU Condition: Polycythemia Vera Date: 2022-08-01 Interventions: Interventional |
RECRUITING |
Study Name: Study to Assess SLN124 in Patients With Polycythemia Vera Condition: Polycythemia Vera Date: 2022-07-29 Interventions: SLN124 is a double-stranded small interfering ribonucleic acid (siRNA) targeting transmembrane protease, serine 6 (TMPRSS6) messenger ribonucleic acid |
Recruiting |
Study Name: Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure Condition: Polycythemia Vera Thrombocythemia, Essential Date: 2016-09-10 Interventions: Drug: No cytoreductive vs cytoreductive drugs No cytoreductive treatment vs cytoreductive drugs (hydroxy |
Not yet recruiting |
Study Name: Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features Condition: Polycythemia Vera Date: 2016-06-18 Interventions: Other: questionnaires • Influence of iron parameters on Patient-reported symptoms as assessed by M |
Completed |
Study Name: Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients Condition: Polycythemia Vera Date: 2015-06-12 Interventions: Drug: Pegylated-Proline-Interferon alpha-2b in a Pre-filled Pen Subjects will continue to receive the do |
Recruiting |
Study Name: Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Are Available. Condition: Polycythemia Vera Date: 2014-11-05 Interventions: Drug: Ruxolitinib |
Active, not recruiting |
Study Name: Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL) Condition: Polycythemia Vera Date: 2014-09-23 |
Active, not recruiting |
Study Name: AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study. Condition: Polycythemia Vera Date: 2014-08-14 Interventions: Drug: Pegylated-Proline-interferon alpha-2b |
Active, not recruiting |
Study Name: Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy. Condition: Polycythemia Vera Date: 2014-01-14 Interventions: Drug: Best Available Therapy B |